Dolutegravir + Lamivudine

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
DovatoAU CA ES EU GB HK MX SG TW US
  • tablet ×7 Dolutegravir 50 mg + Lamivudine 300 mg
  • tablet ×5 Dolutegravir + Lamivudine
Viiv Healthcare B.V.
Dolutegravir 50mg / Lamivudine 300mg tabletsAU ES GB50 mg / 300 mgViiv Healthcare B.V.
dolutegravir + lamivudinaES50 mg / 300 mgViiv Healthcare B.V.
dolutegravir sodium and lamivudineUS50 mg / 300 mgViiV Healthcare Company
lamivudine + dolutegravir sodiumAU——
洛瓦梭膜衣錠TW
  • tablet Dolutegravir + Lamivudine
荷商葛蘭素史克藥廠股份有限公司台灣分公司
DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottleAU
  • tablet Dolutegravir 52.6 mg + Lamivudine 300 mg
ViiV Healthcare Pty Ltd
DOVATO 50 mg/300 mg, comprimé pelliculéFR
  • tablet Dolutegravir + Lamivudine 300 mg
VIIV HEALTHCARE (PAYS-BAS)
ドウベイト配合錠JP
  • tablet Dolutegravir + Lamivudine
ヴィーブヘルスケア

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.